カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒト狂犬病ワクチン（ベロセル）市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Human Rabies Vaccine (Vero Cell) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7883）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7883
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：101
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のヒト狂犬病ワクチン（ベロセル）市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のヒト狂犬病ワクチン（ベロセル）の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のヒト狂犬病ワクチン（ベロセル）市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- ヒト狂犬病ワクチン（ベロセル）の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

ヒト狂犬病ワクチン（ベロセル）市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・0.5ml、1ml

用途別セグメント
・病院、診療所

主要な市場プレーヤー
・Liaoning Chengda、Guangzhou Nuocheng、Ningbo Rong'an、Hualan Bio-vaccine、Sanofi Pasteur SA、Bharat Biotech、Bavarian Nordic、Serum Institute of India Pvt.、Chengdu Kanghua Biology、Changchun Zhuoyi Biology、Dalian Yali Peak、Jilin Huikang Biopharmaceutical Co., Ltd.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒト狂犬病ワクチン（ベロセル）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒト狂犬病ワクチン（ベロセル）メーカーの企業概要、2019年～2022年までのヒト狂犬病ワクチン（ベロセル）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒト狂犬病ワクチン（ベロセル）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ヒト狂犬病ワクチン（ベロセル）の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのヒト狂犬病ワクチン（ベロセル）のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのヒト狂犬病ワクチン（ベロセル）市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびヒト狂犬病ワクチン（ベロセル）の産業チェーンを掲載しています。
・第14、15章では、ヒト狂犬病ワクチン（ベロセル）の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– ヒト狂犬病ワクチン（ベロセル）の概要
– タイプ別分析（2018年vs2022年vs2029年）：0.5ml、1ml
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所
– 世界のヒト狂犬病ワクチン（ベロセル）市場規模・予測
– 世界のヒト狂犬病ワクチン（ベロセル）生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Liaoning Chengda、Guangzhou Nuocheng、Ningbo Rong’an、Hualan Bio-vaccine、Sanofi Pasteur SA、Bharat Biotech、Bavarian Nordic、Serum Institute of India Pvt.、Chengdu Kanghua Biology、Changchun Zhuoyi Biology、Dalian Yali Peak、Jilin Huikang Biopharmaceutical Co., Ltd.
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：0.5ml、1ml
・用途別分析2018年-2029年：病院、診療所
・ヒト狂犬病ワクチン（ベロセル）の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒト狂犬病ワクチン（ベロセル）のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒト狂犬病ワクチン（ベロセル）のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒト狂犬病ワクチン（ベロセル）の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒト狂犬病ワクチン（ベロセル）の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Human Rabies Vaccine (Vero Cell)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 0.5ml
1.3.3 1ml
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Human Rabies Vaccine (Vero Cell) Market Size & Forecast
1.5.1 Global Human Rabies Vaccine (Vero Cell) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Rabies Vaccine (Vero Cell) Sales Quantity (2018-2029)
1.5.3 Global Human Rabies Vaccine (Vero Cell) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Liaoning Chengda
2.1.1 Liaoning Chengda Details
2.1.2 Liaoning Chengda Major Business
2.1.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product and Services
2.1.4 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Liaoning Chengda Recent Developments/Updates
2.2 Guangzhou Nuocheng
2.2.1 Guangzhou Nuocheng Details
2.2.2 Guangzhou Nuocheng Major Business
2.2.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product and Services
2.2.4 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Guangzhou Nuocheng Recent Developments/Updates
2.3 Ningbo Rong’an
2.3.1 Ningbo Rong’an Details
2.3.2 Ningbo Rong’an Major Business
2.3.3 Ningbo Rong’an Human Rabies Vaccine (Vero Cell) Product and Services
2.3.4 Ningbo Rong’an Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ningbo Rong’an Recent Developments/Updates
2.4 Hualan Bio-vaccine
2.4.1 Hualan Bio-vaccine Details
2.4.2 Hualan Bio-vaccine Major Business
2.4.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product and Services
2.4.4 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Hualan Bio-vaccine Recent Developments/Updates
2.5 Sanofi Pasteur SA
2.5.1 Sanofi Pasteur SA Details
2.5.2 Sanofi Pasteur SA Major Business
2.5.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product and Services
2.5.4 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Pasteur SA Recent Developments/Updates
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Product and Services
2.6.4 Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bharat Biotech Recent Developments/Updates
2.7 Bavarian Nordic
2.7.1 Bavarian Nordic Details
2.7.2 Bavarian Nordic Major Business
2.7.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product and Services
2.7.4 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bavarian Nordic Recent Developments/Updates
2.8 Serum Institute of India Pvt.
2.8.1 Serum Institute of India Pvt. Details
2.8.2 Serum Institute of India Pvt. Major Business
2.8.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product and Services
2.8.4 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Serum Institute of India Pvt. Recent Developments/Updates
2.9 Chengdu Kanghua Biology
2.9.1 Chengdu Kanghua Biology Details
2.9.2 Chengdu Kanghua Biology Major Business
2.9.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product and Services
2.9.4 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Chengdu Kanghua Biology Recent Developments/Updates
2.10 Changchun Zhuoyi Biology
2.10.1 Changchun Zhuoyi Biology Details
2.10.2 Changchun Zhuoyi Biology Major Business
2.10.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product and Services
2.10.4 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Changchun Zhuoyi Biology Recent Developments/Updates
2.11 Dalian Yali Peak
2.11.1 Dalian Yali Peak Details
2.11.2 Dalian Yali Peak Major Business
2.11.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product and Services
2.11.4 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Dalian Yali Peak Recent Developments/Updates
2.12 Jilin Huikang Biopharmaceutical Co., Ltd.
2.12.1 Jilin Huikang Biopharmaceutical Co., Ltd. Details
2.12.2 Jilin Huikang Biopharmaceutical Co., Ltd. Major Business
2.12.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product and Services
2.12.4 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments/Updates
3 Competitive Environment: Human Rabies Vaccine (Vero Cell) by Manufacturer
3.1 Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Manufacturer (2018-2023)
3.3 Global Human Rabies Vaccine (Vero Cell) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Rabies Vaccine (Vero Cell) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Rabies Vaccine (Vero Cell) Manufacturer Market Share in 2022
3.4.2 Top 6 Human Rabies Vaccine (Vero Cell) Manufacturer Market Share in 2022
3.5 Human Rabies Vaccine (Vero Cell) Market: Overall Company Footprint Analysis
3.5.1 Human Rabies Vaccine (Vero Cell) Market: Region Footprint
3.5.2 Human Rabies Vaccine (Vero Cell) Market: Company Product Type Footprint
3.5.3 Human Rabies Vaccine (Vero Cell) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Rabies Vaccine (Vero Cell) Market Size by Region
4.1.1 Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2018-2029)
4.1.2 Global Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2018-2029)
4.1.3 Global Human Rabies Vaccine (Vero Cell) Average Price by Region (2018-2029)
4.2 North America Human Rabies Vaccine (Vero Cell) Consumption Value (2018-2029)
4.3 Europe Human Rabies Vaccine (Vero Cell) Consumption Value (2018-2029)
4.4 Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value (2018-2029)
4.5 South America Human Rabies Vaccine (Vero Cell) Consumption Value (2018-2029)
4.6 Middle East and Africa Human Rabies Vaccine (Vero Cell) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2029)
5.2 Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type (2018-2029)
5.3 Global Human Rabies Vaccine (Vero Cell) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2029)
6.2 Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application (2018-2029)
6.3 Global Human Rabies Vaccine (Vero Cell) Average Price by Application (2018-2029)
7 North America
7.1 North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2029)
7.2 North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2029)
7.3 North America Human Rabies Vaccine (Vero Cell) Market Size by Country
7.3.1 North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2018-2029)
7.3.2 North America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2029)
8.2 Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2029)
8.3 Europe Human Rabies Vaccine (Vero Cell) Market Size by Country
8.3.1 Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Rabies Vaccine (Vero Cell) Market Size by Region
9.3.1 Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2029)
10.2 South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2029)
10.3 South America Human Rabies Vaccine (Vero Cell) Market Size by Country
10.3.1 South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2018-2029)
10.3.2 South America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Rabies Vaccine (Vero Cell) Market Size by Country
11.3.1 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Rabies Vaccine (Vero Cell) Market Drivers
12.2 Human Rabies Vaccine (Vero Cell) Market Restraints
12.3 Human Rabies Vaccine (Vero Cell) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Rabies Vaccine (Vero Cell) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Rabies Vaccine (Vero Cell)
13.3 Human Rabies Vaccine (Vero Cell) Production Process
13.4 Human Rabies Vaccine (Vero Cell) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Rabies Vaccine (Vero Cell) Typical Distributors
14.3 Human Rabies Vaccine (Vero Cell) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Liaoning Chengda Basic Information, Manufacturing Base and Competitors
Table 4. Liaoning Chengda Major Business
Table 5. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product and Services
Table 6. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Liaoning Chengda Recent Developments/Updates
Table 8. Guangzhou Nuocheng Basic Information, Manufacturing Base and Competitors
Table 9. Guangzhou Nuocheng Major Business
Table 10. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product and Services
Table 11. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Guangzhou Nuocheng Recent Developments/Updates
Table 13. Ningbo Rong'an Basic Information, Manufacturing Base and Competitors
Table 14. Ningbo Rong'an Major Business
Table 15. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product and Services
Table 16. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Ningbo Rong'an Recent Developments/Updates
Table 18. Hualan Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 19. Hualan Bio-vaccine Major Business
Table 20. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product and Services
Table 21. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Hualan Bio-vaccine Recent Developments/Updates
Table 23. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Pasteur SA Major Business
Table 25. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product and Services
Table 26. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi Pasteur SA Recent Developments/Updates
Table 28. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 29. Bharat Biotech Major Business
Table 30. Bharat Biotech Human Rabies Vaccine (Vero Cell) Product and Services
Table 31. Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bharat Biotech Recent Developments/Updates
Table 33. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 34. Bavarian Nordic Major Business
Table 35. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product and Services
Table 36. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bavarian Nordic Recent Developments/Updates
Table 38. Serum Institute of India Pvt. Basic Information, Manufacturing Base and Competitors
Table 39. Serum Institute of India Pvt. Major Business
Table 40. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product and Services
Table 41. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Serum Institute of India Pvt. Recent Developments/Updates
Table 43. Chengdu Kanghua Biology Basic Information, Manufacturing Base and Competitors
Table 44. Chengdu Kanghua Biology Major Business
Table 45. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product and Services
Table 46. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Chengdu Kanghua Biology Recent Developments/Updates
Table 48. Changchun Zhuoyi Biology Basic Information, Manufacturing Base and Competitors
Table 49. Changchun Zhuoyi Biology Major Business
Table 50. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product and Services
Table 51. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Changchun Zhuoyi Biology Recent Developments/Updates
Table 53. Dalian Yali Peak Basic Information, Manufacturing Base and Competitors
Table 54. Dalian Yali Peak Major Business
Table 55. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product and Services
Table 56. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Dalian Yali Peak Recent Developments/Updates
Table 58. Jilin Huikang Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Jilin Huikang Biopharmaceutical Co., Ltd. Major Business
Table 60. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product and Services
Table 61. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 63. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Human Rabies Vaccine (Vero Cell) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Human Rabies Vaccine (Vero Cell) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Human Rabies Vaccine (Vero Cell), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Human Rabies Vaccine (Vero Cell) Production Site of Key Manufacturer
Table 68. Human Rabies Vaccine (Vero Cell) Market: Company Product Type Footprint
Table 69. Human Rabies Vaccine (Vero Cell) Market: Company Product Application Footprint
Table 70. Human Rabies Vaccine (Vero Cell) New Market Entrants and Barriers to Market Entry
Table 71. Human Rabies Vaccine (Vero Cell) Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Human Rabies Vaccine (Vero Cell) Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Human Rabies Vaccine (Vero Cell) Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Human Rabies Vaccine (Vero Cell) Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Human Rabies Vaccine (Vero Cell) Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Human Rabies Vaccine (Vero Cell) Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Human Rabies Vaccine (Vero Cell) Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Human Rabies Vaccine (Vero Cell) Raw Material
Table 131. Key Manufacturers of Human Rabies Vaccine (Vero Cell) Raw Materials
Table 132. Human Rabies Vaccine (Vero Cell) Typical Distributors
Table 133. Human Rabies Vaccine (Vero Cell) Typical Customers
List of Figures
Figure 1. Human Rabies Vaccine (Vero Cell) Picture
Figure 2. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Type in 2022
Figure 4. 0.5ml Examples
Figure 5. 1ml Examples
Figure 6. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Human Rabies Vaccine (Vero Cell) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Human Rabies Vaccine (Vero Cell) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Human Rabies Vaccine (Vero Cell) Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Human Rabies Vaccine (Vero Cell) Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Human Rabies Vaccine (Vero Cell) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Human Rabies Vaccine (Vero Cell) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Human Rabies Vaccine (Vero Cell) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Human Rabies Vaccine (Vero Cell) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Human Rabies Vaccine (Vero Cell) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Human Rabies Vaccine (Vero Cell) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Human Rabies Vaccine (Vero Cell) Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Human Rabies Vaccine (Vero Cell) Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Region (2018-2029)
Figure 52. China Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Human Rabies Vaccine (Vero Cell) Market Drivers
Figure 73. Human Rabies Vaccine (Vero Cell) Market Restraints
Figure 74. Human Rabies Vaccine (Vero Cell) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Human Rabies Vaccine (Vero Cell) in 2022
Figure 77. Manufacturing Process Analysis of Human Rabies Vaccine (Vero Cell)
Figure 78. Human Rabies Vaccine (Vero Cell) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の蛍光活性化細胞選別（FACS）市場2023年：企業・地域・タイプ・用途別分析
  • 世界の心臓収縮性変調（CCM）市場2023年：企業・地域・タイプ・用途別分析
  • 世界のジューススタイル経口栄養補助食品（ONS）市場2023年：企業・地域・タイプ・用途別分析
  • 世界のデュアルチャンバーバッグ（DCB）市場2023年：企業・地域・タイプ・用途別分析
  • 世界の小容量インジェクション（SVI）市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7883 )"世界のヒト狂犬病ワクチン（ベロセル）市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Human Rabies Vaccine (Vero Cell) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。